Baymycard en es it fr

Baymycard Brand names, Baymycard Analogs

Baymycard Brand Names Mixture

  • No information avaliable

Baymycard Chemical_Formula


Baymycard RX_link

Baymycard fda sheet

Baymycard msds (material safety sheet)

Baymycard Synthesis Reference

No information avaliable

Baymycard Molecular Weight

388.414 g/mol

Baymycard Melting Point

No information avaliable

Baymycard H2O Solubility

No information avaliable

Baymycard State


Baymycard LogP


Baymycard Dosage Forms

No information avaliable

Baymycard Indication


Baymycard Pharmacology

Nisoldipine, a dihydropyridine calcium-channel blocker, is used alone or with an angiotensin-converting enzyme inhibitor, to treat hypertension, chronic stable angina pectoris, and Prinzmetal's variant angina. Nisoldipine is similar to other peripheral vasodilators. Nisoldipine inhibits the influx of extra cellular calcium across the myocardial and vascular smooth muscle cell membranes possibly by deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum. The decrease in intracellular calcium inhibits the contractile processes of the myocardial smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload.

Baymycard Absorption

No information avaliable

Baymycard side effects and Toxicity

No information avaliable

Baymycard Patient Information

Baymycard Organisms Affected

Humans and other mammals